1984
DOI: 10.1073/pnas.81.24.7708
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin.

Abstract: A recombinant plasmid (pSVS dhfr) encoding the pre-S region and the S gene of human hepatitis B virus (HBV) and murine dihydrofolate reductase (DHFR) cDNA has been used for the transfection of Chinese hamster ovary (CHO) DHFR-cells. Selection of clones resistant to methotrexate has permitted amplification of HBV sequences and an increase in production of hepatitis B surface antigen (HBsAg).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
77
0
5

Year Published

1985
1985
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 173 publications
(85 citation statements)
references
References 36 publications
3
77
0
5
Order By: Relevance
“…On the other hand, antibodies against the pHSA receptor which have been shown in serum during acute hepatitis B may have an important role for viral clearance (Alberti et al, 1984;Pontisso et al, 1983b). As a result, it would be useful to use HBsAg particles carrying the pHSA receptor in vaccination programs (Michel et al, 1984). The recombinant adenovirus which is capable of eliciting in vivo both anti-HBs and anti-pHSA receptor antibodies would constitute the basis for an efficient live vaccine.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…On the other hand, antibodies against the pHSA receptor which have been shown in serum during acute hepatitis B may have an important role for viral clearance (Alberti et al, 1984;Pontisso et al, 1983b). As a result, it would be useful to use HBsAg particles carrying the pHSA receptor in vaccination programs (Michel et al, 1984). The recombinant adenovirus which is capable of eliciting in vivo both anti-HBs and anti-pHSA receptor antibodies would constitute the basis for an efficient live vaccine.…”
Section: Discussionmentioning
confidence: 99%
“…The use of recombinant DNA technology which allows the production of 22 nm HBsAg particles in eucaryotic cells is, therefore, needed. Presently, HBsAg particles are produced in vitro in animal cells (Michel et al, 1984;Patzer et al, 1984) or yeast (Miyanohara et al, 1983;Valenzuela et al, 1982) and in vivo through the vaccinia virus used as a vector (Smith et al, 1983). Chimpanzees infected 3864 with a vaccinia virus-HBV recombinant were found to be protected against a further HBV challenge (Moss et al, 1984).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Two larger forms containing pre-S sequences are found in minor quantities, whereas the smallest HBsAg is the predominant component. The HBsAg can be integrated into cellular membranes and secreted as 22-nm particles into the culture supematant (Michel et al, 1984). Using the HBsAg reporter system, kinetics of promoter activities could easily be analyzed under a variety of in vitro conditions.…”
Section: Introductionmentioning
confidence: 99%